Skip to main content

Table 1 Preoperative characteristics of the cohort

From: Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation

 

N = 57

Sex, n (%)

 

 male

51 (89%)

 female

6 (11%)

Age in years, mean (± SD)

57.79 (± 11.75)

Height in cm, mean (± SD)

176 (± 9.0)

Weight in kg, mean (± SD)

80.9 (± 14.4)

Body mass index in kg/m2, mean (± SD)

26.20 (± 4.5)

INTERMACS score, n (%)

 

 1

16 (28%)

 2

12 (21%)

 3

11 (19%)

 4

18 (32%)

Etiology of left ventricular failure, n (%)

 

 Dilated cardiomyopathy

20 (35%)

 Ischemic heart disease

37 (65%)

Past medical history, n (%)

 

 Arterial hypertension

36 (63%)

 Coronary heart disease

36 (63%)

 Defibrillator implant

30 (53%)

 Myocardial infarct

27 (47%)

 PTCA

26 (46%)

 Carotid stents

22 (39%)

 Hyperlipoproteinemia

21 (37%)

 Cardiac surgery

19 (33%)

 Diabetes mellitus

19 (33%)

 COPD

13 (23%)

 Nicotine abuse

13 (23%)

 Syncope

5 (9%)

 Peripheral vascular disease

4 (7%)

 Pacemaker

4 (7%)

 Pulmonary emboli

4 (7%)

 Dialysis

3 (5%)

 Main stem stenosis

2 (4%)

 Cerebrovascular disease

1 (2%)

Mechanical circulatory support

 

 None

38 (67%)

 ECLS only

9 (16%)

 ECLS, IABP

3 (5%)

 IABP only

4 (7%)

 Impella only

3 (5%)

  1. Preoperative characteristics of the cohort
  2. COPD Chronic obstructive pulmonary disease, PTCA Percutaneous transluminal coronary angioplasty, ECLS Extracorporeal life support, IABP Intraarterial balloon pump